Biomarin Pharmaceutical Inc
NASDAQ: BMRN
$65.60
-$1.06 (-1.6%)
Closing Price on November 14, 2024
BMRN Articles
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage and research firms this Tuesday morning. Arch Coal Inc. (NYSE: ACI) Cut to Hold at...
Published:
Last Updated:
These are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Wednesday morning. Amazon.com, Inc. (NASDAQ: AMZN) Reiterated Outperform and raised...
Published:
Last Updated:
These are some of this Thursday’s key analyst upgrades, downgrades, and initiations seen in Wall Street research calls. A-Power Energy Generation Systems (NASDAQ: APWR) Cut to Perform at...
Published:
Last Updated:
Today’s BioHealth Business Daily has many new names and less followed companies, but there are some of the larger movers to consider today as well. We are seeing news-related moves in many stocks...
Published:
Last Updated:
These are this Thursday’s top analyst upgrades, downgrades, and initiations seen from Wall Street research calls early this morning: Aetna Inc. (NYSE: AET) Cut to Sell at Collins Stewart. Alcoa,...
Published:
Last Updated:
These are this Thursday morning’s top 10 analyst upgrades, downgrades, and initiations we have seen in early research calls from Wall Street: ArcelorMittal (NYSE: MT) Raised to Buy at Societe...
Published:
Last Updated:
Today is an unusually active day for many emerging biotech stocks in the news and we are seeing significant moves in response. We have more detail on each with appropriate links through to more...
Published:
Last Updated:
These are the top 10 analyst calls we have seen this Wednesday morning with about two hours until the market opens: Altera (ALTR) and Xilinx (XLNX) Raised to Overweight at Global Crown. Biomarin...
Published:
These are some of the top early bird Analyst Downgrades seen from Wall Street analysts this Thursday morning: Acergy (ACGY) Cut to Sell at Citigroup. BioMarin Pharmaceutical (BMRN) downgraded at...
Published:
Last Updated:
La Jolla Pharmaceutical Company (NASDAQ: LJPC) has been more than just a troubled biotech. It has even been considered an at-risk entity by some traders after it had been down more than 90% at one...
Published:
Last Updated:
These are the top pre-market analyst upgrades and positive calls we are seeing from Wall Street firms this Friday morning with more than two hours until the open. Arm Holdings (ARMH) Raised to Buy at...
Published:
Today almost feels like the "March of Biotech-inguins" because most of the movers were small companies you might otherwise miss. Here were the big movers: Barrier Therapeutics (NASDAQ: BTRX) ran...
Published:
Last Updated:
On tonight’s MAD MONEY on CNBC, Jim Cramer came out and wanted to give his BUY, SELL, or HOLD recommendations on his Top 9 Picks from 2007 now that we are into 2008. He already gave some of this...
Published:
Last Updated:
On tonight’s MAD MONEY on CNBC, Jim Cramer kicked off 2008 by being somewhat cautious on the volatility in 2008. Cramer said he wants to Add gold to the portfolio with Barrick Gold (NYSE: ABX)...
Published:
Last Updated:
Stock Tickers: ANF, ARO, AEO, ANN, ADSK, BMRN, CA, CHS, C, COGN, CWTR, ETR, GPS, GOOG, JCG, LF, MA, MSFT, ORH, ORCL, PAS, PNWIF, PT, RIMM, JAVA, SYMC, UA, URBN Abercrombie & Fitch (ANF) started...
Published: